For the relief of Francisca Burciaga-Amaro.
Legislative Progress
Introduced
April 28, 2021
Latest Action
October 19, 2021
Primary Sponsor
Jesús G. "Chuy" GarcíaDemocratic(IL)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
86pct
174d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Provides for the relief of Francisca Burciaga-Amaro.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2022 · third_quarter · Health Issues
GBS/CIDP research at NIH FDA, Patient Focused Drug Development Initiative CIDP, MMN Home Infusion Healthcare Reform, Patient Protections H.R. 4724 HR 2905 S.2633 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Referred to the Subcommittee on Immigration and Citizenship.
Referred to the House Committee on the Judiciary.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
GBS/CIDP research at NIH FDA, Patient Focused Drug Development Initiative CIDP, MMN Home Infusion Healthcare Reform, Patient Protections H.R. 4724 HR 2905 S.2633 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
GBS/CIDP research at NIH FDA, Patient Focused Drug Development Initiative CIDP, MMN Home Infusion Healthcare Reform, Patient Protections H.R. 4724 HR 2905 S.2633 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Awareness and education activities at CDC Patient-focused Drug Development at FDA 21st Century Cures Implementation Research programs at NIH Medicaid Cranial Prosthetics Legislation Healthcare Reform, Patient Protections HR 2905 S.2633 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
GBS/CIDP research at NIH FDA, Patient Focused Drug Development Initiative CIDP, MMN Home Infusion Healthcare Reform, Patient Protections H.R. 4724 HR 2905 S.2633 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Awareness and education activities at CDC Patient-focused Drug Development at FDA 21st Century Cures Implementation Research programs at NIH Medicaid Cranial Prosthetics Legislation Healthcare Reform, Patient Protections HR 2905 S.2633 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
GBS/CIDP research at NIH FDA, Patient Focused Drug Development Initiative CIDP, MMN Home Infusion Healthcare Reform, Patient Protections H.R. 4724 HR 2905 S.2633 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
Awareness and education activities at CDC Patient-focused Drug Development at FDA 21st Century Cures Implementation Research programs at NIH Medicaid Cranial Prosthetics Legislation Healthcare Reform, Patient Protections HR 2905 S.2633 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
GBS/CIDP research at NIH FDA, Patient Focused Drug Development Initiative CIDP, MMN Home Infusion Healthcare Reform, Patient Protections H.R. 4724 HR 2905 S.2633 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Health Issues
Awareness and education activities at CDC Patient-focused Drug Development at FDA 21st Century Cures Implementation Research programs at NIH Medicaid Cranial Prosthetics Legislation Healthcare Reform, Patient Protections HR 2905 S.2633 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Health Issues
GBS/CIDP research at NIH FDA, Patient Focused Drug Development Initiative CIDP, MMN Home Infusion Healthcare Reform, Patient Protections H.R. 4724 HR 2905 S.2633 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Health Issues
Awareness and education activities at CDC Patient-focused Drug Development at FDA 21st Century Cures Implementation Research programs at NIH Medicaid Cranial Prosthetics Legislation Healthcare Reform, Patient Protections HR 2905 S.2633 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Health Issues
GBS/CIDP research at NIH FDA, Patient Focused Drug Development Initiative CIDP, MMN Home Infusion Healthcare Reform, Patient Protections H.R. 4724 HR 2905 S.2633 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Health Issues
Awareness and education activities at CDC Patient-focused Drug Development at FDA 21st Century Cures Implementation Research programs at NIH Medicaid Cranial Prosthetics Legislation Healthcare Reform, Patient Protections HR 2905 S.2633 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE